{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:41:47Z","timestamp":1791150107248,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.jns.2006.08.004","type":"journal-article","created":{"date-parts":[[2006,9,27]],"date-time":"2006-09-27T07:30:07Z","timestamp":1159342207000},"page":"120-123","source":"Crossref","is-referenced-by-count":114,"title":["CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration"],"prefix":"10.1016","volume":"250","author":[{"given":"Kenichi","family":"Yasui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanbayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Kusumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2006.08.004_bib1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.jns.2006.08.004_bib2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1389-9457(04)90001-9","article-title":"Sleep, sleep disorders and hypocretin (orexin)","volume":"5","author":"Mignot","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.jns.2006.08.004_bib3","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions","volume":"57","author":"Ripley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.08.004_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/01.WNL.0000078194.53210.48","article-title":"Low levels of ventricular CSF orexin\/hypocretin in advanced PD","volume":"6","author":"Drouot","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.08.004_bib5","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.58.3.498","article-title":"Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness","volume":"58","author":"Overeem","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.08.004_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy","volume":"10","author":"Steele","year":"1964","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2006.08.004_bib7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mds.1120","article-title":"Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy","volume":"16","author":"Boeve","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2006.08.004_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jpsychores.2004.02.001","article-title":"Sleep and quantitative EEG in neurodegenerative disorders","volume":"56","author":"Petit","year":"2004","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jns.2006.08.004_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1389-9457(01)00097-1","article-title":"Sleep and periodic limb movements in corticobasal degeneration","volume":"3","author":"Wetter","year":"2002","journal-title":"Sleep Med"},{"key":"10.1016\/j.jns.2006.08.004_bib10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/sleep\/20.10.891","article-title":"Subclinical REM sleep behavior disorder in a patient with corticobasal degeneration","volume":"20","author":"Kimura","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.jns.2006.08.004_bib11","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1002\/ana.410320721","article-title":"Criteria for diagnosing Parkinson's disease","volume":"32","author":"Calne","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2006.08.004_bib12","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.08.004_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele\u2013Richardson\u2013Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2006.08.004_bib14","series-title":"Neurodegenerative Diseases","first-page":"877","article-title":"Cortical-basal ganglionic degeneration","author":"Lang","year":"1994"},{"key":"10.1016\/j.jns.2006.08.004_bib15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.1130","article-title":"Low CSF hypocretin (orexin) and altered energy homeostasis in human narcolepsy","volume":"50","author":"Nishino","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2006.08.004_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000079749","article-title":"Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness","volume":"52","author":"Baumann","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jns.2006.08.004_bib17","first-page":"1053","article-title":"Excessive daytime sleepiness and low CSF orexin-A\/hypocretin-I levels in a patient with probable progressive supranuclear palsy","volume":"55","author":"Hattori","year":"2003","journal-title":"No To Shinkei"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X06003686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X06003686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T06:08:32Z","timestamp":1555826912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X06003686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":17,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0022510X06003686"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2006.08.004","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}